newsfilter
← Latest News
ACCESS Newswire·

Biophytis has Filed with the EMA for Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 15, 2023 / Biophytis SA , a clinical-stage biotechnology company focused on the development